1. Liu, Furong, Liao, Zhibin, Qin, Lu, Zhang, Bixiang, Zhang, Zhanguo. 2023. Targeting VPS72 inhibits ACTL6A/MYC axis activity in HCC progression. In Hepatology (Baltimore, Md.), 78, 1384-1401. doi:10.1097/HEP.0000000000000268. https://pubmed.ncbi.nlm.nih.gov/36631007/
2. Xu, Xiaolong, Wang, Wei, He, Yi, Yao, Yiqun, Yang, Bo. 2024. Prognostic marker VPS72 could promote the malignant progression of prostate cancer. In BMC cancer, 24, 713. doi:10.1186/s12885-024-12488-z. https://pubmed.ncbi.nlm.nih.gov/38858662/
3. Jostes, Sina, Vardabasso, Chiara, Dong, Joanna, Hasson, Dan, Bernstein, Emily. 2024. H2A.Z chaperones converge on E2F target genes for melanoma cell proliferation. In Genes & development, 38, 336-353. doi:10.1101/gad.351318.123. https://pubmed.ncbi.nlm.nih.gov/38744503/
4. Cao, Jun, Zhang, Hao, Xie, Xin, Wang, Wei. 2024. Expression Analysis of VPS72 and Associated Biological Behaviors in Colon Cancer. In International journal of general medicine, 17, 3433-3442. doi:10.2147/IJGM.S465064. https://pubmed.ncbi.nlm.nih.gov/39135633/
5. Jostes, Sina, Vardabasso, Chiara, Dong, Joanna, Hasson, Dan, Bernstein, Emily. 2023. H2A.Z chaperones converge on histone H4 acetylation for melanoma cell proliferation. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.11.26.568747. https://pubmed.ncbi.nlm.nih.gov/38076914/
6. Yang, Zhou, Feng, Xiao, Yu, Haoyuan, Jia, Changchang, Fu, Binsheng. 2025. Identification of tumor immune infiltration-associated VPS72 and prognostic significance of VPS72 and CD8A in hepatocellular carcinoma. In Discover oncology, 16, 410. doi:10.1007/s12672-025-02017-0. https://pubmed.ncbi.nlm.nih.gov/40146476/
智鼠故事 
